Vitamin B12 Market Is Projected To Reach US$ 575.4 Million By 2034
A new fact.mr report
estimated the global vitamin b12 market to be valued at US$ 312.4 million in
2024 and thereafter expand at a CAGR of 6.3% from 2024 to 2034.
Vitamin b12 is
clinically recommended for a person suffering from digestive disorders such as
celiac disease. Vitamin b12 absorption requires an acidic environment in the
stomach. Some digestive disorders, such as atrophic gastritis, can reduce the
production of stomach acid, which in turn impairs the absorption of vitamin
b12.
Get a free
sample copy of this report: https://www.factmr.com/connectus/sample?flag=s&rep_id=9925
In several regions, there
is a notable trend toward transitioning to vegetarian diets, as indicated by
estimates from surveys. Government recommendations support the supplementation
and monitoring of vitamin b12 intake, underscoring its crucial role in maintaining
nerve health and energy production. Vitamin b12 is highlighted in dietary
guidelines from various nations, reflecting an increasing awareness and
emphasis on health, which is expected to drive market growth.
Supplementation with
vitamin b12 can help individuals overcome this deficiency caused by decreased
stomach acid.
·
According to the national
institutes of health, in 2023, approximately 20 million people in america
experienced digestive disorders. This factor is projected to drive market
growth in this country.
Governments of developing
nations such as india are implementing policies to provide fortified food and
beverages for people to fulfill their daily micronutrient dosage.
Key takeaways from market study
·
The global vitamin b12 market is projected
to expand at 6.3% CAGR and reach US$ 575.4 million by 2034-end.
·
The market expanded at a CAGR of 6.8% from
2019 to 2023.
·
Top market players include charkit
chemical, chem kart india pvt. Ltd., koninklijke dsm n.v., pfizer inc.,
sanofi-aventis, bristol-myers squibb company, apotheca inc., johnlee
pharmaceutical pvt ltd., american regent, and Merck group.
·
Vitamin b12 in tablet form is estimated to
occupy 40% market share in 2024.
·
The United States market is projected to
reach a valuation of US$ 97.6 million by the end of 2034.
“Consumption of micronutrients such as
vitamin b12 is linked to lowered risks of anemia, chronic diseases and
depression. Rising awareness of the significance of vitamin b12 supplementation
is driving market growth,” says a fact.mr analyst.
Market growth stratagems
To produce better quality supplements and
ensure environmentally friendly production, manufacturing companies are
investing heavily in research and development and adhering to sustainable
practices.
·
On 9 january 2023, euroapi announced a us$
43.3 million investment for the expansion of its business by increasing its
production capacity by 60% at its normandy plant. This strategic step was
supported by the government of france.
Manufacturers are offering vitamin b12
supplements to customers in different forms like tablets, powder, liquid, and
capsules. In addition to manufacturing, companies are allocating investments
towards packaging.
·
In 2022, dsm made investments in advanced
technology for packaging, specifically focusing on primary packaging, which
includes the production of vitamin b12 in fully compostable stick packs. This
initiative aligns with the company's sustainability goals, providing them with
a reusable and recyclable packaging solution that offers a sustainable
competitive advantage.
Key companies profiled
·
Chem kart india pvt ltd.
·
Pfizer inc.
·
Sanofi-aventis
·
Bristol-myers squibb company
·
Konikilijike dsm n.v.
·
Charkit chemical.
·
American regent
·
Apotheca inc.
·
Merck group
·
Johnlee pharmaceutical pvt. Ltd.
·
Others
Read More: https://www.factmr.com/report/vitamin-b12-market
Country-wise insights
“Boosting
expenditure on health and wellbeing”
The us market is
anticipated to grow at a compound annual growth rate (cagr) of 5.5% until 2034.
Based on a recent gallup poll, 5% of adults in the nation identify as
vegetarians. With the increasing accessibility of plant-based choices, the
shift toward veganism is predicted to escalate. Consequently, the demand for
natural sources of vitamin b12 might decrease. Considering the robust
purchasing capacity of north american consumers and their inclination towards
health investments, the market for vitamin b12 supplements is forecasted to
experience a consistent expansion in the foreseeable future.
More valuable insights on offer
Fact.MR, in its new offering, presents an
unbiased analysis of the vitamin b12 market, presenting historical market data
for 2019 to 2023 and forecast statistics from 2024 to 2034.
The study reveals
essential insights based on form (tablets, powder, liquid, capsules) and end-use industry (fortified food & beverages,
pharmaceuticals, health & personal care, agriculture, animal feed,
poultry), regions of the world (north america, latin america, western europe,
eastern europe, east asia, south asia & oceania, and the middle east &
africa).
Explore more related studies published by fact.mr research:
Specialty feed additives market: The global
specialty feed additives market enjoys
a valuation of US$ 12.3 billion and
is expected to reach US$ 20.5
billion by the end of 2033.
Poultry processing equipment market: The
valuation of the global poultry processing equipment market is US$ 3.8 billion in 2022 and is
estimated to reach US$ 5.8 billion by
2032-end.
Lime oil market: Expanding at a 6.7% CAGR from 2023 to 2033, the global lime oil
market is projected to nearly double in valuation from US$ 521
million in 2023 to US$ 1 billion by the end of 2033.
Contact:
us sales office
11140 rockville pike
suite 400
rockville, md 20852
united states
tel: +1 (628) 251-1583, +353-1-4434-232 (d)
sales team: sales@factmr.com
follow us: linkedin | twitter | blog
Comments
Post a Comment